Norgine

Norgine strengthens rare disease portfolio with acquisition of Theravia
Yahoo Finance
Wed, 04/16/25 - 11:18 am
M&A
Theravia
Norgine
Rare Diseases
Santarus licenses GI-disorder drug to Norgine
Marketwatch
Mon, 10/12/09 - 09:19 am
Norgine
Santarus